U.S., Dec. 2 -- ClinicalTrials.gov registry received information related to the study (NCT07256197) titled 'A Randomized Trial of PCSK9 Inhibitors in the Treatment of Calcific Aortic Stenosis' on Nov. 20.
Brief Summary: Calcific aortic stenosis (CAS) can cause severe adverse cardiac events, but there are currently no effective drugs that can prevent or delay the progression of the disease. Our trial aims to investigate the effect of PCSK9 inhibitors on preventing or delaying the progression of CAS.
Study Start Date: Dec. 01
Study Type: INTERVENTIONAL
Condition:
Aortic Stenosis, Calcific
Intervention:
DRUG: Treatment with PCSK9 inhibitors
Patients in experimental group are treated with PCSK9 inhibitors (Tafolecimab subcutaneously eve...